Resultados de la búsqueda 141-150 of 4791 for ☃구글 검색 상위 등록 ※프로그램:GTTVTT 구글SEO상단노출 구글백링크프로그램 구글SEO백링크상위노출☃

1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Proton beam radiation therapy is one of the treatments for men with prostate cancer who have localized disease. The benefit of the combination with androgen ...

2. Neurología - Ensayos clínicos - Mayo Clinic

   Jacksonville, Fla., Scottsdale/Phoenix, Ariz. The purpose of this study is to develop a biorepository of blood samples from cancer patients participating in the ...

3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Rochester, Minn. This is a randomized Phase 2 study of novel SEQUEnced immunotherapy (pembrolizumab) with anti-angiogenesis and chemotherapy in advanced gastric ...

4. Nefrología e hipertensión - Ensayos clínicos - Mayo Clinic

   The primary purpose of this study is to assess the feasibility of performing lung and kidney and lung ultrasound elastography among patients with critical ...

5. Nefrología e hipertensión - Ensayos clínicos - Mayo Clinic

   The natural course of autosomal dominant polycystic kidney disease (ADPKD) is highly variable and typically characterized by progressive enlargement of cysts ...

6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

8. Nefrología e hipertensión - Ensayos clínicos - Mayo Clinic

   The natural course of autosomal dominant polycystic kidney disease (ADPKD) is highly variable and typically characterized by progressive enlargement of cysts ...

9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Systemic chemotherapy, targeted agents and immunotherapy have largely been ineffective in treatment of LM, in part due to limited CNS/CSF penetration. New ...

10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...